1. Home
  2. WLYB vs AORT Comparison

WLYB vs AORT Comparison

Compare WLYB & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLYB
  • AORT
  • Stock Information
  • Founded
  • WLYB 1807
  • AORT 1984
  • Country
  • WLYB United States
  • AORT United States
  • Employees
  • WLYB N/A
  • AORT N/A
  • Industry
  • WLYB Books
  • AORT Medical/Dental Instruments
  • Sector
  • WLYB Consumer Discretionary
  • AORT Health Care
  • Exchange
  • WLYB Nasdaq
  • AORT Nasdaq
  • Market Cap
  • WLYB 2.1B
  • AORT 1.9B
  • IPO Year
  • WLYB N/A
  • AORT 1993
  • Fundamental
  • Price
  • WLYB $37.05
  • AORT $45.26
  • Analyst Decision
  • WLYB
  • AORT Strong Buy
  • Analyst Count
  • WLYB 0
  • AORT 6
  • Target Price
  • WLYB N/A
  • AORT $43.97
  • AVG Volume (30 Days)
  • WLYB 583.0
  • AORT 288.0K
  • Earning Date
  • WLYB 12-04-2025
  • AORT 11-06-2025
  • Dividend Yield
  • WLYB 3.81%
  • AORT N/A
  • EPS Growth
  • WLYB N/A
  • AORT N/A
  • EPS
  • WLYB 1.78
  • AORT N/A
  • Revenue
  • WLYB $1,670,600,000.00
  • AORT $405,037,000.00
  • Revenue This Year
  • WLYB $0.86
  • AORT $14.91
  • Revenue Next Year
  • WLYB $2.66
  • AORT $10.90
  • P/E Ratio
  • WLYB $20.20
  • AORT N/A
  • Revenue Growth
  • WLYB N/A
  • AORT 7.44
  • 52 Week Low
  • WLYB $36.20
  • AORT $21.97
  • 52 Week High
  • WLYB $52.90
  • AORT $45.79
  • Technical
  • Relative Strength Index (RSI)
  • WLYB 42.08
  • AORT 73.76
  • Support Level
  • WLYB $37.05
  • AORT $41.98
  • Resistance Level
  • WLYB $37.55
  • AORT $42.78
  • Average True Range (ATR)
  • WLYB 0.58
  • AORT 1.03
  • MACD
  • WLYB -0.01
  • AORT 0.36
  • Stochastic Oscillator
  • WLYB 21.60
  • AORT 91.69

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: